Cyclosporin A
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro
5
CYCLOSPORIN A PRODUCTION BY GENETICALLY IMPROVED FUSANTS OF TOLYPOCLADIUM INFLATUM
9
Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
10
Optimizing Fermentation Medium to Produce Cyclosporin a Using Response Surface Methodology
6
Cyclosporin A Enhances Callus Formation in Rabbit Tibia Fractures
6
Cyclosporin A inhibits CD40 ligand expression in T lymphocytes
7
Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method
13
Longstanding Obliterative Panarteritis in Kawasaki Disease: Lack of Cyclosporin A Effect
9
Absence of the mdr1a P Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
9
Differential effect of cyclosporin A on activation signaling in human T cell lines
7
Suppression of feline coronavirus replication in vitro by cyclosporin A
7
Characterization of folding cores in the cyclophilin A cyclosporin A complex
9
Effect of Cyclosporin a on the Tumor Microenvironment
164
Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method
13
Cyclosporin a Inhibition of experimental autoimmune uveitis in Lewis rats
5
MR imaging of reversible cyclosporin A induced neurotoxicity
9
Effect of cyclosporin A treatment on the production of antibody in insulin dependent (type I) diabetic patients
7
Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion
10
Etiology of Cortical and White Matter Lesions in Cyclosporin A and FK 506 Neurotoxicity
14
Effects of cyclosporin a on rat skeletal biomechanical properties
9